Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
Taiwan
· Delayed Price · Currency is TWD 54.80
+0.90 (1.67%)
Apr 29, 2026, 1:30 PM CST
TPEX:4747 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1,050 | 1,070 | 1,088 | 168.47 | 202.23 | Upgrade
|
| Trading Asset Securities | 102.3 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 1,152 | 1,070 | 1,088 | 168.47 | 202.23 | Upgrade
|
| Cash Growth | 7.64% | -1.61% | 545.58% | -16.70% | -31.60% | Upgrade
|
| Accounts Receivable | 114.56 | 119.17 | 124.74 | 115.37 | 91.64 | Upgrade
|
| Other Receivables | 1.02 | 1.14 | 1.68 | 0.92 | 0.97 | Upgrade
|
| Receivables | 115.59 | 120.31 | 126.42 | 116.29 | 92.61 | Upgrade
|
| Inventory | 188.47 | 140.9 | 138.81 | 127.03 | 146.48 | Upgrade
|
| Prepaid Expenses | 0.65 | 3.11 | 4.68 | 2.18 | 4.56 | Upgrade
|
| Other Current Assets | 0.85 | 2.45 | 1.26 | 0.57 | 0.62 | Upgrade
|
| Total Current Assets | 1,457 | 1,337 | 1,359 | 414.53 | 446.49 | Upgrade
|
| Property, Plant & Equipment | 606.75 | 599.23 | 605.59 | 592.17 | 382.72 | Upgrade
|
| Long-Term Investments | 15.75 | 14.01 | 15.77 | 15.38 | 15.41 | Upgrade
|
| Other Intangible Assets | - | 1.41 | 2.83 | 4.24 | 5.66 | Upgrade
|
| Long-Term Deferred Tax Assets | 3.13 | 2.64 | 2.96 | 2.96 | 3.14 | Upgrade
|
| Other Long-Term Assets | 10.83 | 11.15 | 7.03 | 9.94 | 173.72 | Upgrade
|
| Total Assets | 2,094 | 1,965 | 1,993 | 1,039 | 1,027 | Upgrade
|
| Accounts Payable | 58.61 | 39.96 | 67.82 | 33.32 | 34.99 | Upgrade
|
| Short-Term Debt | 200 | 60 | 60 | 60 | 80 | Upgrade
|
| Current Portion of Long-Term Debt | 60.96 | - | - | - | - | Upgrade
|
| Current Income Taxes Payable | 0.17 | 11.37 | 21.43 | 16.47 | 13.24 | Upgrade
|
| Current Unearned Revenue | 6.15 | 7.86 | 7.35 | 7.06 | 8.39 | Upgrade
|
| Other Current Liabilities | 58.32 | 51.95 | 63.41 | 50.72 | 42.3 | Upgrade
|
| Total Current Liabilities | 384.21 | 171.14 | 220.01 | 167.56 | 178.91 | Upgrade
|
| Long-Term Debt | - | 90.22 | 100.83 | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.16 | - | 0.15 | - | - | Upgrade
|
| Total Liabilities | 384.37 | 261.36 | 320.99 | 167.56 | 178.91 | Upgrade
|
| Common Stock | 453.81 | 449.32 | 436.68 | 300.19 | 300.19 | Upgrade
|
| Additional Paid-In Capital | 1,074 | 1,049 | 1,038 | 400.86 | 400.86 | Upgrade
|
| Retained Earnings | 190.37 | 217.49 | 196.32 | 180.85 | 157.4 | Upgrade
|
| Comprehensive Income & Other | -9.06 | -11.61 | 0.68 | -10.24 | -10.21 | Upgrade
|
| Shareholders' Equity | 1,709 | 1,704 | 1,672 | 871.66 | 848.24 | Upgrade
|
| Total Liabilities & Equity | 2,094 | 1,965 | 1,993 | 1,039 | 1,027 | Upgrade
|
| Total Debt | 260.96 | 150.22 | 160.83 | 60 | 80 | Upgrade
|
| Net Cash (Debt) | 890.87 | 919.84 | 926.78 | 108.47 | 122.23 | Upgrade
|
| Net Cash Growth | -3.15% | -0.75% | 754.40% | -11.26% | -26.22% | Upgrade
|
| Net Cash Per Share | 19.13 | 19.76 | 24.40 | 3.61 | 4.06 | Upgrade
|
| Filing Date Shares Outstanding | 45.38 | 44.93 | 43.67 | 30.02 | 30.02 | Upgrade
|
| Total Common Shares Outstanding | 45.38 | 44.93 | 43.67 | 30.02 | 30.02 | Upgrade
|
| Working Capital | 1,073 | 1,166 | 1,139 | 246.96 | 267.58 | Upgrade
|
| Book Value Per Share | 37.67 | 37.92 | 38.29 | 29.04 | 28.26 | Upgrade
|
| Tangible Book Value | 1,709 | 1,702 | 1,669 | 867.41 | 842.58 | Upgrade
|
| Tangible Book Value Per Share | 37.67 | 37.89 | 38.22 | 28.90 | 28.07 | Upgrade
|
| Land | 431.69 | 431.69 | 431.69 | 431.69 | 265.1 | Upgrade
|
| Buildings | 95.63 | 94.98 | 93.64 | 90.23 | 89.32 | Upgrade
|
| Machinery | 283.98 | 282.6 | 262.63 | 251.35 | 186.43 | Upgrade
|
| Construction In Progress | 21.24 | 7.02 | 19.82 | 4.45 | 16.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.